XML 43 R30.htm IDEA: XBRL DOCUMENT v3.21.1
Stock-Based Payments (Details) - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Stock Options/SARs, Employee Stock Purchase Plan (ESPP), Restricted Stock and Restricted Stock Units and Performance Units Disclosures [Line Items]    
Stock-Based Compensation Expenses $ 35,000,000 $ 40,000,000
Common Shares Available for Grant 2,000,000  
Aggregate Maximum of Common Shares 20,000,000  
Stock Options And SARs    
Stock Options/SARs, Employee Stock Purchase Plan (ESPP), Restricted Stock and Restricted Stock Units and Performance Units Disclosures [Line Items]    
Stock-based compensation expense related to stock options, SAR and ESPP grants $ 10,000,000 $ 14,000,000
Unrecognized compensation expense $ 47,000,000  
Weighted average period over which unrecognized compensation expense will be recognized (in years) 1 year 10 months 24 days  
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract]    
Weighted Average Fair Value of Grants (price per share) $ 17.03 $ 19.67
Expected Volatility (in hundredths) 47.18% 33.43%
Risk-Free Interest Rate (in hundredths) 0.28% 1.43%
Dividend Yield (in hundredths) 3.25% 1.60%
Expected Life (in years) 5 years 2 months 12 days 5 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]    
Outstanding at January 1 (in shares) 10,186,000 9,395,000
Granted (in shares) 7,000 9,000
Exercised (1) (in shares) [1] (26,000) (23,000)
Forfeited (in shares) (103,000) (47,000)
Outstanding at March 31 (2) [2] 10,064,000 9,334,000
Stock Options and SARs Vested or Expected to Vest (3) (in shares) [3] 9,749,000 8,998,000
Stock Options and SARs Exercisable at March 31 (4) (in shares) [4] 6,288,000 5,249,000
Intrinsic Value of Stock Options/SARs Exercised [1] $ 200,000 $ 400,000
Intrinsic Value of Stock Options/SARs Outstanding [2] $ 71,000,000 $ 0
Weighted Average Remaining Contractual Life for Stock Options/SARs Outstanding (in years) [2] 4 years 4 years
Intrinsic Value of Stock Options/SARs Vested or Expected to Vest [3] $ 66,000,000 $ 0
Weighted average remaining contractual life for stock options/SARs vested or expected to vest (in years) [3] 4 years 4 years
Aggregate Intrinsic Value for Exercisable Units [4] $ 3,000,000 $ 0
Weighted average remaining contractual life for exercisable options/SARs (in years) [4] 3 years 2 years 9 months 18 days
Weighted Average Grant Price Stock Option and SARs [Rollforward]    
Outstanding at January 1 (price per share) $ 84.08 $ 94.53
Granted (price per share) 53.98 75.44
Exercised (1) (price per share) [1] 63.25 69.59
Forfeited (price per share) 89.21 96.81
Outstanding at March 31 (2) [2] 84.06 94.56
Vested or Expected to Vest (3) (price per share) [3] 84.74 94.55
Exercisable at March 31 (4) [4] 96.47 94.33
ESPP    
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract]    
Weighted Average Fair Value of Grants (price per share) $ 14.69 $ 20.80
Expected Volatility (in hundredths) 54.99% 35.24%
Risk-Free Interest Rate (in hundredths) 0.09% 1.56%
Dividend Yield (in hundredths) 3.41% 1.56%
Expected Life (in years) 6 months 6 months
Restricted Stock And Restricted Stock Units    
Stock Options/SARs, Employee Stock Purchase Plan (ESPP), Restricted Stock and Restricted Stock Units and Performance Units Disclosures [Line Items]    
Unrecognized compensation expense $ 153,000,000  
Weighted average period over which unrecognized compensation expense will be recognized (in years) 1 year 6 months  
Share-Based Compensation Arrangement By Restricted Stock And Restricted Stock Units Compensation Cost $ 24,000,000 $ 25,000,000
Restricted Stock/Restricted Stock Units and Performance Units [Roll Forward]    
Outstanding at January 1 (in shares) 4,742,000 4,546,000
Granted (in shares) 12,000 26,000
Released (1) (in shares) [5] (430,000) (259,000)
Forfeited (in shares) (25,000) (11,000)
Outstanding at March 31 (3) [6] 4,299,000 4,302,000
Intrinsic value released during the year [5] $ 31,000,000 $ 11,000,000
Aggregate intrinsic value of stock and units outstanding [6] $ 312,000,000 $ 155,000,000
Weighted Average Grant Price Restricted Stock and Restricted Stock Units [Roll Forward]    
Outstanding at January 1 (price per share) $ 74.97 $ 90.16
Granted (price per share) 60.27 63.48
Released (2) (price per share) [5] 90.27 88.19
Forfeited (price per share) 71.16 89.86
Outstanding at March 31 (3) (price per share) [6] $ 73.42 $ 90.12
Performance Unit    
Stock Options/SARs, Employee Stock Purchase Plan (ESPP), Restricted Stock and Restricted Stock Units and Performance Units Disclosures [Line Items]    
Stock-Based Compensation Expenses $ 1,000,000 $ 1,000,000
Unrecognized compensation expense $ 7,000,000  
Weighted average period over which unrecognized compensation expense will be recognized (in years) 1 year 10 months 24 days  
Restricted Stock/Restricted Stock Units and Performance Units [Roll Forward]    
Outstanding at January 1 (in shares) 613,000 598,000
Granted (in shares) 8,000 0
Granted for Performance Multiple (1) [7] 19,000 66,000
Released (1) (in shares) [8] (98,000) (121,000)
Forfeited (in shares) 0 0
Outstanding at March 31 (3) [9] 542,000 [10] 543,000
Intrinsic value released during the year $ 6,000,000 [8] $ 9,000,000
Aggregate intrinsic value of stock and units outstanding [9] $ 39,000,000 $ 20,000,000
Weighted Average Grant Price Restricted Stock and Restricted Stock Units [Roll Forward]    
Outstanding at January 1 (price per share) $ 79.10 $ 92.19
Granted (price per share) 49.86 0
Granted for Performance Multiple (1) (in dollars per share) [7] 96.29 100.95
Released (2) (price per share) [8] 96.29 104.69
Forfeited (price per share) 0 0
Outstanding at March 31 (3) (price per share) [9] $ 76.18 $ 90.48
Performance Units and Performance Stock Disclosures [Abstract]    
Performance Period for Performance Units and Shares 3 years  
Minimum Performance Multiple at the Completion of the Performance Period 0.00%  
Maximum Performance Multiple at the Completion of the Performance Period 200.00%  
Performance Multiple Applied at the Completion Period [7] 125.00% 150.00%
Minimum Performance Units and Stock Allowed to be Outstanding [10] 76,785  
Maximum Performance Units Allowed to be Outstanding [10] 1,007,705  
Lease and Well    
Stock Options/SARs, Employee Stock Purchase Plan (ESPP), Restricted Stock and Restricted Stock Units and Performance Units Disclosures [Line Items]    
Stock-Based Compensation Expenses $ 14,000,000 $ 15,000,000
Gathering and Processing Costs    
Stock Options/SARs, Employee Stock Purchase Plan (ESPP), Restricted Stock and Restricted Stock Units and Performance Units Disclosures [Line Items]    
Stock-Based Compensation Expenses 0 0
Exploration Costs    
Stock Options/SARs, Employee Stock Purchase Plan (ESPP), Restricted Stock and Restricted Stock Units and Performance Units Disclosures [Line Items]    
Stock-Based Compensation Expenses 6,000,000 7,000,000
General and Administrative    
Stock Options/SARs, Employee Stock Purchase Plan (ESPP), Restricted Stock and Restricted Stock Units and Performance Units Disclosures [Line Items]    
Stock-Based Compensation Expenses $ 15,000,000 $ 18,000,000
[1] The total intrinsic value of stock options/SARs exercised during the three months ended March 31, 2021 and 2020 was $0.2 million and $0.4 million, respectively. The intrinsic value is based upon the difference between the market price of EOG's common stock on the date of exercise and the grant price of the stock options/SARs.
[2] The total intrinsic value of stock options/SARs outstanding at March 31, 2021 and 2020 was $71 million and zero, respectively. At March 31, 2021 and 2020, the weighted average remaining contractual life was 4.0 years.
[3] The total intrinsic value of stock options/SARs vested or expected to vest at March 31, 2021 and 2020 was $66 million and zero, respectively. At March 31, 2021 and 2020, the weighted average remaining contractual life was 4.0 years.
[4] The total intrinsic value of stock options/SARs exercisable at March 31, 2021 and 2020 was $3 million and zero, respectively. At March 31, 2021 and 2020, the weighted average remaining contractual life was 3.0 years and 2.8 years, respectively.
[5] The total intrinsic value of restricted stock and restricted stock units released during the three months ended March 31, 2021 and 2020 was $31 million and $11 million, respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date the restricted stock and restricted stock units are released.
[6] The total intrinsic value of restricted stock and restricted stock units outstanding at March 31, 2021 and 2020 was $312 million and $155 million, respectively.
[7] Upon completion of the Performance Period for the performance units granted in 2017 and 2016, a performance multiple of 125% and 150%, respectively, was applied to each of the grants resulting in additional grants of performance units in February 2021 and February 2020, respectively.
[8] The total intrinsic value of performance units released during the three months ended March 31, 2021 and 2020 was $6 million and $9 million, respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date the performance units are released.
[9] The total intrinsic value of performance units outstanding at March 31, 2021 and 2020 was approximately $39 million and $20 million, respectively.
[10] Upon the application of the relevant performance multiple at the completion of each of the remaining Performance Periods, a minimum of 76,785 and a maximum of 1,007,705 performance units could be outstanding.